
----------------------------------
original sentence: 
Erbitux: Japanese approval highlights a growing trend for personalized therapy | TradingMarkets.com  New ETF Book by Larry Connors Click here to read more
 Erbitux: Japanese approval highlights a growing trend for personalized therapy
Posted on: Tue, 30 Mar 2010 05:59:47 EDT
, ,  Do you know when to trade  &  ?

POS tagged sentence: 
[('Erbitux', 'NNP'), (':', ':'), ('Japanese', 'JJ'), ('approval', 'NN'), ('highlights', 'NNS'), ('a', 'DT'), ('growing', 'VBG'), ('trend', 'NN'), ('for', 'IN'), ('personalized', 'JJ'), ('therapy', 'NN'), ('|', ':'), ('TradingMarkets.com', 'JJ'), ('New', 'NNP'), ('ETF', 'NNP'), ('Book', 'NNP'), ('by', 'IN'), ('Larry', 'NNP'), ('Connors', 'NNP'), ('Click', 'NNP'), ('here', 'RB'), ('to', 'TO'), ('read', 'VB'), ('more', 'JJR'), ('Erbitux', 'NNP'), (':', ':'), ('Japanese', 'JJ'), ('approval', 'NN'), ('highlights', 'NNS'), ('a', 'DT'), ('growing', 'VBG'), ('trend', 'NN'), ('for', 'IN'), ('personalized', 'JJ'), ('therapy', 'NN'), ('Posted', 'NNP'), ('on', 'IN'), (':', ':'), ('Tue', 'NNP'), (',', ','), ('30', 'CD'), ('Mar', 'NNP'), ('2010', 'CD'), ('05', 'CD'), (':', ':'), ('59', 'CD'), (':', ':'), ('47', 'CD'), ('EDT', 'NNP'), (',', ','), (',', ','), ('Do', 'NNP'), ('you', 'PRP'), ('know', 'VB'), ('when', 'WRB'), ('to', 'TO'), ('trade', 'VB'), ('&', 'CC'), ('?', '.')]


ERTAGGED sentence: (S   (GPE Erbitux/NNP)   :/:   (GPE Japanese/JJ)   approval/NN   highlights/NNS   a/DT   growing/VBG   trend/NN   for/IN   personalized/JJ   therapy/NN   |/:   TradingMarkets.com/JJ   (ORGANIZATION New/NNP)   ETF/NNP   Book/NNP   by/IN   (PERSON Larry/NNP Connors/NNP Click/NNP)   here/RB   to/TO   read/VB   more/JJR   (PERSON Erbitux/NNP)   :/:   (GPE Japanese/JJ)   approval/NN   highlights/NNS   a/DT   growing/VBG   trend/NN   for/IN   personalized/JJ   therapy/NN   (PERSON Posted/NNP)   on/IN   :/:   Tue/NNP   ,/,   30/CD   Mar/NNP   2010/CD   05/CD   :/:   59/CD   :/:   47/CD   EDT/NNP   ,/,   ,/,   Do/NNP   you/PRP   know/VB   when/WRB   to/TO   trade/VB   &/CC   ?/.)
----------------------------------
original sentence: 
Check for a  from TradingMarkets  Mar 30, 2010 Datamonitor via COMTEX In a move that mirrors earlier FDA and EMA decisions, the PMDA in Japan has granted additional approval for the use of Erbitux in combination with first line chemotherapy for the treatment of colorectal cancer.

POS tagged sentence: 
[('Check', 'NNP'), ('for', 'IN'), ('a', 'DT'), ('from', 'IN'), ('TradingMarkets', 'NNPS'), ('Mar', 'NNP'), ('30', 'CD'), (',', ','), ('2010', 'CD'), ('Datamonitor', 'NNP'), ('via', 'IN'), ('COMTEX', 'NNP'), ('In', 'NNP'), ('a', 'DT'), ('move', 'NN'), ('that', 'WDT'), ('mirrors', 'VBZ'), ('earlier', 'JJR'), ('FDA', 'NNP'), ('and', 'CC'), ('EMA', 'NNP'), ('decisions', 'NNS'), (',', ','), ('the', 'DT'), ('PMDA', 'NNP'), ('in', 'IN'), ('Japan', 'NNP'), ('has', 'VBZ'), ('granted', 'VBN'), ('additional', 'JJ'), ('approval', 'NN'), ('for', 'IN'), ('the', 'DT'), ('use', 'NN'), ('of', 'IN'), ('Erbitux', 'NNP'), ('in', 'IN'), ('combination', 'NN'), ('with', 'IN'), ('first', 'JJ'), ('line', 'NN'), ('chemotherapy', 'NN'), ('for', 'IN'), ('the', 'DT'), ('treatment', 'NN'), ('of', 'IN'), ('colorectal', 'JJ'), ('cancer', 'NN'), ('.', '.')]


ERTAGGED sentence: (S   (GPE Check/NNP)   for/IN   a/DT   from/IN   (ORGANIZATION TradingMarkets/NNPS)   Mar/NNP   30/CD   ,/,   2010/CD   Datamonitor/NNP   via/IN   (ORGANIZATION COMTEX/NNP)   In/NNP   a/DT   move/NN   that/WDT   mirrors/VBZ   earlier/JJR   (ORGANIZATION FDA/NNP)   and/CC   (ORGANIZATION EMA/NNP)   decisions/NNS   ,/,   the/DT   (ORGANIZATION PMDA/NNP)   in/IN   (GPE Japan/NNP)   has/VBZ   granted/VBN   additional/JJ   approval/NN   for/IN   the/DT   use/NN   of/IN   (GPE Erbitux/NNP)   in/IN   combination/NN   with/IN   first/JJ   line/NN   chemotherapy/NN   for/IN   the/DT   treatment/NN   of/IN   colorectal/JJ   cancer/NN   ./.)
----------------------------------
original sentence: 
The decision is likely to strengthen Erbitux's position in Japan, giving it an edge over rival Avastin, and marks another step in the growing trend toward personalized therapy in oncology.

POS tagged sentence: 
[('The', 'DT'), ('decision', 'NN'), ('is', 'VBZ'), ('likely', 'JJ'), ('to', 'TO'), ('strengthen', 'VB'), ('Erbitux', 'NNP'), ("'s", 'POS'), ('position', 'NN'), ('in', 'IN'), ('Japan', 'NNP'), (',', ','), ('giving', 'VBG'), ('it', 'PRP'), ('an', 'DT'), ('edge', 'NN'), ('over', 'IN'), ('rival', 'NN'), ('Avastin', 'NNP'), (',', ','), ('and', 'CC'), ('marks', 'NNS'), ('another', 'DT'), ('step', 'NN'), ('in', 'IN'), ('the', 'DT'), ('growing', 'VBG'), ('trend', 'NN'), ('toward', 'IN'), ('personalized', 'JJ'), ('therapy', 'NN'), ('in', 'IN'), ('oncology', 'NN'), ('.', '.')]


ERTAGGED sentence: (S   The/DT   decision/NN   is/VBZ   likely/JJ   to/TO   strengthen/VB   (PERSON Erbitux/NNP)   's/POS   position/NN   in/IN   (GPE Japan/NNP)   ,/,   giving/VBG   it/PRP   an/DT   edge/NN   over/IN   rival/NN   (PERSON Avastin/NNP)   ,/,   and/CC   marks/NNS   another/DT   step/NN   in/IN   the/DT   growing/VBG   trend/NN   toward/IN   personalized/JJ   therapy/NN   in/IN   oncology/NN   ./.)
----------------------------------
original sentence: 
The Japanese Pharmaceutical and Medical Devices Agency PMDA has granted approval to Erbitux cetuximab; Eli Lilly/Merck Serono/Bristol Myers Squibb in combination with chemotherapy for the first line treatment of unresectable, advanced or recurrent colorectal cancer patients with wild type KRAS tumors.

POS tagged sentence: 
[('The', 'DT'), ('Japanese', 'JJ'), ('Pharmaceutical', 'NNP'), ('and', 'CC'), ('Medical', 'NNP'), ('Devices', 'NNPS'), ('Agency', 'NNP'), ('PMDA', 'NNP'), ('has', 'VBZ'), ('granted', 'VBN'), ('approval', 'NN'), ('to', 'TO'), ('Erbitux', 'NNP'), ('cetuximab', 'NN'), (';', ':'), ('Eli', 'NNP'), ('Lilly/Merck', 'NNP'), ('Serono/Bristol', 'NNP'), ('Myers', 'NNP'), ('Squibb', 'NNP'), ('in', 'IN'), ('combination', 'NN'), ('with', 'IN'), ('chemotherapy', 'NN'), ('for', 'IN'), ('the', 'DT'), ('first', 'JJ'), ('line', 'NN'), ('treatment', 'NN'), ('of', 'IN'), ('unresectable', 'JJ'), (',', ','), ('advanced', 'VBD'), ('or', 'CC'), ('recurrent', 'NN'), ('colorectal', 'NN'), ('cancer', 'NN'), ('patients', 'NNS'), ('with', 'IN'), ('wild', 'JJ'), ('type', 'NN'), ('KRAS', 'NNP'), ('tumors', 'NNS'), ('.', '.')]


ERTAGGED sentence: (S   The/DT   (GPE Japanese/JJ)   (ORGANIZATION Pharmaceutical/NNP)   and/CC   (ORGANIZATION Medical/NNP Devices/NNPS Agency/NNP)   (ORGANIZATION PMDA/NNP)   has/VBZ   granted/VBN   approval/NN   to/TO   (GPE Erbitux/NNP)   cetuximab/NN   ;/:   (PERSON Eli/NNP)   Lilly/Merck/NNP   Serono/Bristol/NNP   Myers/NNP   Squibb/NNP   in/IN   combination/NN   with/IN   chemotherapy/NN   for/IN   the/DT   first/JJ   line/NN   treatment/NN   of/IN   unresectable/JJ   ,/,   advanced/VBD   or/CC   recurrent/NN   colorectal/NN   cancer/NN   patients/NNS   with/IN   wild/JJ   type/NN   (ORGANIZATION KRAS/NNP)   tumors/NNS   ./.)Up/down number phrases to consider:
verb phrases to consider:
	(VERB has/VBZ granted/VBN approval/NN)
	(VERB advanced/VBD)

tagged sentence:
	 advanced	res:1
noun phrases to consider:
	(NOUN The/DT Japanese/JJ Pharmaceutical/NNP)
	(NOUN Medical/NNP Devices/NNPS Agency/NNP PMDA/NNP)
	(NOUN Erbitux/NNP cetuximab/NN)
	(NOUN Eli/NNP Lilly/Merck/NNP Serono/Bristol/NNP Myers/NNP)
	(NOUN Squibb/NNP)
	(NOUN combination/NN)
	(NOUN chemotherapy/NN)
	(NOUN the/DT first/JJ line/NN treatment/NN)
	(NOUN unresectable/JJ)
	(NOUN recurrent/NN colorectal/NN cancer/NN patients/NNS)
	(NOUN wild/JJ type/NN KRAS/NNP tumors/NNS)

----------------------------------
original sentence: 
This extended use approval follows a product label change for Erbitux, as a result of the submission of additional clinical trial data from the Phase III CRYSTAL study to the PMDA.

POS tagged sentence: 
[('This', 'DT'), ('extended', 'VBD'), ('use', 'NN'), ('approval', 'NN'), ('follows', 'VBZ'), ('a', 'DT'), ('product', 'NN'), ('label', 'NN'), ('change', 'NN'), ('for', 'IN'), ('Erbitux', 'NNP'), (',', ','), ('as', 'IN'), ('a', 'DT'), ('result', 'NN'), ('of', 'IN'), ('the', 'DT'), ('submission', 'NN'), ('of', 'IN'), ('additional', 'JJ'), ('clinical', 'JJ'), ('trial', 'NN'), ('data', 'NNS'), ('from', 'IN'), ('the', 'DT'), ('Phase', 'NNP'), ('III', 'NNP'), ('CRYSTAL', 'NNP'), ('study', 'NN'), ('to', 'TO'), ('the', 'DT'), ('PMDA', 'NNP'), ('.', '.')]


ERTAGGED sentence: (S   This/DT   extended/VBD   use/NN   approval/NN   follows/VBZ   a/DT   product/NN   label/NN   change/NN   for/IN   (PERSON Erbitux/NNP)   ,/,   as/IN   a/DT   result/NN   of/IN   the/DT   submission/NN   of/IN   additional/JJ   clinical/JJ   trial/NN   data/NNS   from/IN   the/DT   (ORGANIZATION Phase/NNP)   III/NNP   (ORGANIZATION CRYSTAL/NNP)   study/NN   to/TO   the/DT   (ORGANIZATION PMDA/NNP)   ./.)
----------------------------------
original sentence: 
The CRYSTAL study randomized 1,198 metastatic colorectal cancer patients to receive standard first line FOLFIRI 5 fluorouracil, leucovorin and irinotecan chemotherapy with or without Erbitux.

POS tagged sentence: 
[('The', 'DT'), ('CRYSTAL', 'NNP'), ('study', 'NN'), ('randomized', 'VBD'), ('1,198', 'CD'), ('metastatic', 'JJ'), ('colorectal', 'JJ'), ('cancer', 'NN'), ('patients', 'NNS'), ('to', 'TO'), ('receive', 'VB'), ('standard', 'JJ'), ('first', 'JJ'), ('line', 'NN'), ('FOLFIRI', 'NNP'), ('5', 'CD'), ('fluorouracil', 'NN'), (',', ','), ('leucovorin', 'NN'), ('and', 'CC'), ('irinotecan', 'JJ'), ('chemotherapy', 'NN'), ('with', 'IN'), ('or', 'CC'), ('without', 'IN'), ('Erbitux', 'NNP'), ('.', '.')]


ERTAGGED sentence: (S   The/DT   (ORGANIZATION CRYSTAL/NNP)   study/NN   randomized/VBD   1,198/CD   metastatic/JJ   colorectal/JJ   cancer/NN   patients/NNS   to/TO   receive/VB   standard/JJ   first/JJ   line/NN   FOLFIRI/NNP   5/CD   fluorouracil/NN   ,/,   leucovorin/NN   and/CC   irinotecan/JJ   chemotherapy/NN   with/IN   or/CC   without/IN   (PERSON Erbitux/NNP)   ./.)
----------------------------------
original sentence: 
Initial results showed that the benefits of adding Erbitux to chemotherapy are greater in wild type KRAS patients, while those with mutant KRAS derive no benefit at all.

POS tagged sentence: 
[('Initial', 'JJ'), ('results', 'NNS'), ('showed', 'VBD'), ('that', 'IN'), ('the', 'DT'), ('benefits', 'NNS'), ('of', 'IN'), ('adding', 'VBG'), ('Erbitux', 'NNP'), ('to', 'TO'), ('chemotherapy', 'VB'), ('are', 'VBP'), ('greater', 'JJR'), ('in', 'IN'), ('wild', 'JJ'), ('type', 'NN'), ('KRAS', 'NNP'), ('patients', 'NNS'), (',', ','), ('while', 'IN'), ('those', 'DT'), ('with', 'IN'), ('mutant', 'JJ'), ('KRAS', 'NNS'), ('derive', 'JJ'), ('no', 'DT'), ('benefit', 'NN'), ('at', 'IN'), ('all', 'DT'), ('.', '.')]


ERTAGGED sentence: (S   Initial/JJ   results/NNS   showed/VBD   that/IN   the/DT   benefits/NNS   of/IN   adding/VBG   (PERSON Erbitux/NNP)   to/TO   chemotherapy/VB   are/VBP   greater/JJR   in/IN   wild/JJ   type/NN   (ORGANIZATION KRAS/NNP)   patients/NNS   ,/,   while/IN   those/DT   with/IN   mutant/JJ   (ORGANIZATION KRAS/NNS)   derive/JJ   no/DT   benefit/NN   at/IN   all/DT   ./.)
----------------------------------
original sentence: 
Updated results presented at the American Society of Clinical Oncology's Gastrointestinal Cancers Symposium in January 2010 showed that the addition of Erbitux offers a statistically significant overall survival benefit for wild type KRAS patients.

POS tagged sentence: 
[('Updated', 'NNP'), ('results', 'NNS'), ('presented', 'VBD'), ('at', 'IN'), ('the', 'DT'), ('American', 'NNP'), ('Society', 'NNP'), ('of', 'IN'), ('Clinical', 'NNP'), ('Oncology', 'NNP'), ("'s", 'POS'), ('Gastrointestinal', 'NNP'), ('Cancers', 'NNP'), ('Symposium', 'NNP'), ('in', 'IN'), ('January', 'NNP'), ('2010', 'CD'), ('showed', 'VBD'), ('that', 'IN'), ('the', 'DT'), ('addition', 'NN'), ('of', 'IN'), ('Erbitux', 'NNP'), ('offers', 'NNS'), ('a', 'DT'), ('statistically', 'RB'), ('significant', 'JJ'), ('overall', 'JJ'), ('survival', 'NN'), ('benefit', 'NN'), ('for', 'IN'), ('wild', 'JJ'), ('type', 'NN'), ('KRAS', 'NNP'), ('patients', 'NNS'), ('.', '.')]


ERTAGGED sentence: (S   (GPE Updated/NNP)   results/NNS   presented/VBD   at/IN   the/DT   (ORGANIZATION American/NNP Society/NNP)   of/IN   (PERSON Clinical/NNP Oncology/NNP)   's/POS   Gastrointestinal/NNP   Cancers/NNP   Symposium/NNP   in/IN   January/NNP   2010/CD   showed/VBD   that/IN   the/DT   addition/NN   of/IN   (GPE Erbitux/NNP)   offers/NNS   a/DT   statistically/RB   significant/JJ   overall/JJ   survival/NN   benefit/NN   for/IN   wild/JJ   type/NN   (ORGANIZATION KRAS/NNP)   patients/NNS   ./.)
----------------------------------
original sentence: 
Wild type KRAS patients in the Erbitux arm showed overall survival of 23.5 months compared to 20.0 months in those receiving chemotherapy alone.

POS tagged sentence: 
[('Wild', 'NNP'), ('type', 'NN'), ('KRAS', 'NNP'), ('patients', 'NNS'), ('in', 'IN'), ('the', 'DT'), ('Erbitux', 'NNP'), ('arm', 'NN'), ('showed', 'VBD'), ('overall', 'JJ'), ('survival', 'NN'), ('of', 'IN'), ('23.5', 'CD'), ('months', 'NNS'), ('compared', 'VBN'), ('to', 'TO'), ('20.0', 'CD'), ('months', 'NNS'), ('in', 'IN'), ('those', 'DT'), ('receiving', 'VBG'), ('chemotherapy', 'NN'), ('alone', 'RB'), ('.', '.')]


ERTAGGED sentence: (S   (GPE Wild/NNP)   type/NN   (ORGANIZATION KRAS/NNP)   patients/NNS   in/IN   the/DT   (ORGANIZATION Erbitux/NNP)   arm/NN   showed/VBD   overall/JJ   survival/NN   of/IN   23.5/CD   months/NNS   compared/VBN   to/TO   20.0/CD   months/NNS   in/IN   those/DT   receiving/VBG   chemotherapy/NN   alone/RB   ./.)
----------------------------------
original sentence: 
In addition, the combination of Erbitux and chemotherapy significantly reduced the risk of disease progression by 30%, and increased tumor response from 40% to 57%.

POS tagged sentence: 
[('In', 'IN'), ('addition', 'NN'), (',', ','), ('the', 'DT'), ('combination', 'NN'), ('of', 'IN'), ('Erbitux', 'NNP'), ('and', 'CC'), ('chemotherapy', 'NN'), ('significantly', 'RB'), ('reduced', 'VBN'), ('the', 'DT'), ('risk', 'NN'), ('of', 'IN'), ('disease', 'NN'), ('progression', 'NN'), ('by', 'IN'), ('30', 'CD'), ('%', 'NN'), (',', ','), ('and', 'CC'), ('increased', 'VBD'), ('tumor', 'NN'), ('response', 'NN'), ('from', 'IN'), ('40', 'CD'), ('%', 'NN'), ('to', 'TO'), ('57', 'CD'), ('%', 'NN'), ('.', '.')]


ERTAGGED sentence: (S   In/IN   addition/NN   ,/,   the/DT   combination/NN   of/IN   (GPE Erbitux/NNP)   and/CC   chemotherapy/NN   significantly/RB   reduced/VBN   the/DT   risk/NN   of/IN   disease/NN   progression/NN   by/IN   30/CD   %/NN   ,/,   and/CC   increased/VBD   tumor/NN   response/NN   from/IN   40/CD   %/NN   to/TO   57/CD   %/NN   ./.)
----------------------------------
original sentence: 
In the US and Europe, Erbitux's label was changed to reflect the KRAS data in 2009 and 2008, respectively.

POS tagged sentence: 
[('In', 'IN'), ('the', 'DT'), ('US', 'NNP'), ('and', 'CC'), ('Europe', 'NNP'), (',', ','), ('Erbitux', 'NNP'), ("'s", 'POS'), ('label', 'NN'), ('was', 'VBD'), ('changed', 'VBN'), ('to', 'TO'), ('reflect', 'VB'), ('the', 'DT'), ('KRAS', 'NNP'), ('data', 'NNS'), ('in', 'IN'), ('2009', 'CD'), ('and', 'CC'), ('2008', 'CD'), (',', ','), ('respectively', 'RB'), ('.', '.')]


ERTAGGED sentence: (S   In/IN   the/DT   (ORGANIZATION US/NNP)   and/CC   (GPE Europe/NNP)   ,/,   (PERSON Erbitux/NNP)   's/POS   label/NN   was/VBD   changed/VBN   to/TO   reflect/VB   the/DT   (ORGANIZATION KRAS/NNP)   data/NNS   in/IN   2009/CD   and/CC   2008/CD   ,/,   respectively/RB   ./.)
----------------------------------
original sentence: 
The PMDA's decision to change Erbitux's label in Japan adds further impetus to the growing trend in oncology towards personalized medicine.

POS tagged sentence: 
[('The', 'DT'), ('PMDA', 'NNP'), ("'s", 'POS'), ('decision', 'NN'), ('to', 'TO'), ('change', 'VB'), ('Erbitux', 'NNP'), ("'s", 'POS'), ('label', 'NN'), ('in', 'IN'), ('Japan', 'NNP'), ('adds', 'VBZ'), ('further', 'JJ'), ('impetus', 'NN'), ('to', 'TO'), ('the', 'DT'), ('growing', 'VBG'), ('trend', 'NN'), ('in', 'IN'), ('oncology', 'NN'), ('towards', 'NNS'), ('personalized', 'VBD'), ('medicine', 'NN'), ('.', '.')]


ERTAGGED sentence: (S   The/DT   (ORGANIZATION PMDA/NNP)   's/POS   decision/NN   to/TO   change/VB   (PERSON Erbitux/NNP)   's/POS   label/NN   in/IN   (GPE Japan/NNP)   adds/VBZ   further/JJ   impetus/NN   to/TO   the/DT   growing/VBG   trend/NN   in/IN   oncology/NN   towards/NNS   personalized/VBD   medicine/NN   ./.)
----------------------------------
original sentence: 
Given that two thirds of colorectal cancer patients carry the wild type KRAS gene, demand for Erbitux will continue to rise.

POS tagged sentence: 
[('Given', 'RB'), ('that', 'IN'), ('two', 'CD'), ('thirds', 'NNS'), ('of', 'IN'), ('colorectal', 'JJ'), ('cancer', 'NN'), ('patients', 'NNS'), ('carry', 'VBP'), ('the', 'DT'), ('wild', 'NN'), ('type', 'NN'), ('KRAS', 'NNP'), ('gene', 'NN'), (',', ','), ('demand', 'NN'), ('for', 'IN'), ('Erbitux', 'NNP'), ('will', 'MD'), ('continue', 'VB'), ('to', 'TO'), ('rise', 'VB'), ('.', '.')]


ERTAGGED sentence: (S   Given/RB   that/IN   two/CD   thirds/NNS   of/IN   colorectal/JJ   cancer/NN   patients/NNS   carry/VBP   the/DT   wild/NN   type/NN   (ORGANIZATION KRAS/NNP)   gene/NN   ,/,   demand/NN   for/IN   (PERSON Erbitux/NNP)   will/MD   continue/VB   to/TO   rise/VB   ./.)
----------------------------------
original sentence: 
This is especially significant in Japan, which has the highest incidence rate of colorectal cancer on a global scale.

POS tagged sentence: 
[('This', 'DT'), ('is', 'VBZ'), ('especially', 'RB'), ('significant', 'JJ'), ('in', 'IN'), ('Japan', 'NNP'), (',', ','), ('which', 'WDT'), ('has', 'VBZ'), ('the', 'DT'), ('highest', 'JJS'), ('incidence', 'NN'), ('rate', 'NN'), ('of', 'IN'), ('colorectal', 'JJ'), ('cancer', 'NN'), ('on', 'IN'), ('a', 'DT'), ('global', 'JJ'), ('scale', 'NN'), ('.', '.')]


ERTAGGED sentence: (S   This/DT   is/VBZ   especially/RB   significant/JJ   in/IN   (GPE Japan/NNP)   ,/,   which/WDT   has/VBZ   the/DT   highest/JJS   incidence/NN   rate/NN   of/IN   colorectal/JJ   cancer/NN   on/IN   a/DT   global/JJ   scale/NN   ./.)
----------------------------------
original sentence: 
This is likely due to the traditional diet in this area, which is high in salts, nitrates and smoked or pickled foods, a known risk factor for gastrointestinal cancers.

POS tagged sentence: 
[('This', 'DT'), ('is', 'VBZ'), ('likely', 'JJ'), ('due', 'JJ'), ('to', 'TO'), ('the', 'DT'), ('traditional', 'JJ'), ('diet', 'NN'), ('in', 'IN'), ('this', 'DT'), ('area', 'NN'), (',', ','), ('which', 'WDT'), ('is', 'VBZ'), ('high', 'JJ'), ('in', 'IN'), ('salts', 'NNS'), (',', ','), ('nitrates', 'VBZ'), ('and', 'CC'), ('smoked', 'VBN'), ('or', 'CC'), ('pickled', 'VBN'), ('foods', 'NNS'), (',', ','), ('a', 'DT'), ('known', 'NN'), ('risk', 'NN'), ('factor', 'NN'), ('for', 'IN'), ('gastrointestinal', 'JJ'), ('cancers', 'NNS'), ('.', '.')]


ERTAGGED sentence: (S   This/DT   is/VBZ   likely/JJ   due/JJ   to/TO   the/DT   traditional/JJ   diet/NN   in/IN   this/DT   area/NN   ,/,   which/WDT   is/VBZ   high/JJ   in/IN   salts/NNS   ,/,   nitrates/VBZ   and/CC   smoked/VBN   or/CC   pickled/VBN   foods/NNS   ,/,   a/DT   known/NN   risk/NN   factor/NN   for/IN   gastrointestinal/JJ   cancers/NNS   ./.)
----------------------------------
original sentence: 
An established screening program for colorectal cancer exists in Japan, which is another contributor to the high incidence seen here.

POS tagged sentence: 
[('An', 'DT'), ('established', 'VBN'), ('screening', 'VBG'), ('program', 'NN'), ('for', 'IN'), ('colorectal', 'JJ'), ('cancer', 'NN'), ('exists', 'NNS'), ('in', 'IN'), ('Japan', 'NNP'), (',', ','), ('which', 'WDT'), ('is', 'VBZ'), ('another', 'DT'), ('contributor', 'NN'), ('to', 'TO'), ('the', 'DT'), ('high', 'JJ'), ('incidence', 'NN'), ('seen', 'VBN'), ('here', 'RB'), ('.', '.')]


ERTAGGED sentence: (S   An/DT   established/VBN   screening/VBG   program/NN   for/IN   colorectal/JJ   cancer/NN   exists/NNS   in/IN   (GPE Japan/NNP)   ,/,   which/WDT   is/VBZ   another/DT   contributor/NN   to/TO   the/DT   high/JJ   incidence/NN   seen/VBN   here/RB   ./.)
----------------------------------
original sentence: 
If a personalized regimen proves more effective in treating metastatic colorectal cancer, it will further strengthen Erbitux's position in this market and give it an edge over rival Avastin bevacizumab; Genentech/Roche .

POS tagged sentence: 
[('If', 'IN'), ('a', 'DT'), ('personalized', 'VBN'), ('regimen', 'NN'), ('proves', 'NNS'), ('more', 'RBR'), ('effective', 'JJ'), ('in', 'IN'), ('treating', 'NN'), ('metastatic', 'JJ'), ('colorectal', 'NN'), ('cancer', 'NN'), (',', ','), ('it', 'PRP'), ('will', 'MD'), ('further', 'RB'), ('strengthen', 'VB'), ('Erbitux', 'NNP'), ("'s", 'POS'), ('position', 'NN'), ('in', 'IN'), ('this', 'DT'), ('market', 'NN'), ('and', 'CC'), ('give', 'VB'), ('it', 'PRP'), ('an', 'DT'), ('edge', 'NN'), ('over', 'IN'), ('rival', 'NN'), ('Avastin', 'NNP'), ('bevacizumab', 'NN'), (';', ':'), ('Genentech/Roche', 'NNP'), ('.', '.')]


ERTAGGED sentence: (S   If/IN   a/DT   personalized/VBN   regimen/NN   proves/NNS   more/RBR   effective/JJ   in/IN   treating/NN   metastatic/JJ   colorectal/NN   cancer/NN   ,/,   it/PRP   will/MD   further/RB   strengthen/VB   (PERSON Erbitux/NNP)   's/POS   position/NN   in/IN   this/DT   market/NN   and/CC   give/VB   it/PRP   an/DT   edge/NN   over/IN   rival/NN   (PERSON Avastin/NNP)   bevacizumab/NN   ;/:   Genentech/Roche/NNP   ./.)
----------------------------------
original sentence: 
http://www.datamonitor.com Republication or redistribution, including by framing or similar means, is expressly prohibited without prior written consent.

POS tagged sentence: 
[('http', 'NN'), (':', ':'), ('//www.datamonitor.com', 'JJ'), ('Republication', 'NN'), ('or', 'CC'), ('redistribution', 'NN'), (',', ','), ('including', 'VBG'), ('by', 'IN'), ('framing', 'NN'), ('or', 'CC'), ('similar', 'JJ'), ('means', 'NNS'), (',', ','), ('is', 'VBZ'), ('expressly', 'RB'), ('prohibited', 'VBN'), ('without', 'IN'), ('prior', 'RB'), ('written', 'VBN'), ('consent', 'NN'), ('.', '.')]


ERTAGGED sentence: (S   http/NN   :/:   //www.datamonitor.com/JJ   Republication/NN   or/CC   redistribution/NN   ,/,   including/VBG   by/IN   framing/NN   or/CC   similar/JJ   means/NNS   ,/,   is/VBZ   expressly/RB   prohibited/VBN   without/IN   prior/RB   written/VBN   consent/NN   ./.)
----------------------------------
original sentence: 
Datamonitor shall not be liable for errors or delays in the content, or for any actions taken in reliance thereon For full details on Bristol Myers Squibb Co BMY .

POS tagged sentence: 
[('Datamonitor', 'NNP'), ('shall', 'MD'), ('not', 'RB'), ('be', 'VB'), ('liable', 'JJ'), ('for', 'IN'), ('errors', 'NNS'), ('or', 'CC'), ('delays', 'NNS'), ('in', 'IN'), ('the', 'DT'), ('content', 'NN'), (',', ','), ('or', 'CC'), ('for', 'IN'), ('any', 'DT'), ('actions', 'NNS'), ('taken', 'VBN'), ('in', 'IN'), ('reliance', 'NN'), ('thereon', 'NN'), ('For', 'IN'), ('full', 'JJ'), ('details', 'NNS'), ('on', 'IN'), ('Bristol', 'NNP'), ('Myers', 'NNP'), ('Squibb', 'NNP'), ('Co', 'NNP'), ('BMY', 'NNP'), ('.', '.')]


ERTAGGED sentence: (S   (GPE Datamonitor/NNP)   shall/MD   not/RB   be/VB   liable/JJ   for/IN   errors/NNS   or/CC   delays/NNS   in/IN   the/DT   content/NN   ,/,   or/CC   for/IN   any/DT   actions/NNS   taken/VBN   in/IN   reliance/NN   thereon/NN   For/IN   full/JJ   details/NNS   on/IN   (PERSON Bristol/NNP Myers/NNP Squibb/NNP Co/NNP BMY/NNP)   ./.)
----------------------------------
original sentence: 
Bristol Myers Squibb Co BMY has Short Term PowerRatings at TradingMarkets.

POS tagged sentence: 
[('Bristol', 'NNP'), ('Myers', 'NNP'), ('Squibb', 'NNP'), ('Co', 'NNP'), ('BMY', 'NNP'), ('has', 'VBZ'), ('Short', 'NNP'), ('Term', 'NNP'), ('PowerRatings', 'NNP'), ('at', 'IN'), ('TradingMarkets', 'NNPS'), ('.', '.')]


ERTAGGED sentence: (S   (GPE Bristol/NNP)   (ORGANIZATION Myers/NNP Squibb/NNP Co/NNP)   BMY/NNP   has/VBZ   (PERSON Short/NNP Term/NNP)   PowerRatings/NNP   at/IN   (ORGANIZATION TradingMarkets/NNPS)   ./.)
----------------------------------
original sentence: 
Details on Bristol Myers Squibb Co BMY Short Term PowerRatings is available at For full details on Merck & Co MRK .

POS tagged sentence: 
[('Details', 'NNS'), ('on', 'IN'), ('Bristol', 'NNP'), ('Myers', 'NNP'), ('Squibb', 'NNP'), ('Co', 'NNP'), ('BMY', 'NNP'), ('Short', 'NNP'), ('Term', 'NNP'), ('PowerRatings', 'NNP'), ('is', 'VBZ'), ('available', 'JJ'), ('at', 'IN'), ('For', 'NNP'), ('full', 'JJ'), ('details', 'NNS'), ('on', 'IN'), ('Merck', 'NNP'), ('&', 'CC'), ('Co', 'NNP'), ('MRK', 'NNP'), ('.', '.')]


ERTAGGED sentence: (S   Details/NNS   on/IN   (PERSON Bristol/NNP Myers/NNP Squibb/NNP Co/NNP)   BMY/NNP   Short/NNP   Term/NNP   PowerRatings/NNP   is/VBZ   available/JJ   at/IN   (ORGANIZATION For/NNP)   full/JJ   details/NNS   on/IN   (ORGANIZATION Merck/NNP)   &/CC   Co/NNP   MRK/NNP   ./.)Up/down number phrases to consider:
verb phrases to consider:
	(VERB   is/VBZ   available/JJ   at/IN   For/NNP   full/JJ   details/NNS   on/IN   Merck/NNP)
noun phrases to consider:
	(NOUN Details/NNS)
	(NOUN Bristol/NNP Myers/NNP Squibb/NNP Co/NNP)
	(NOUN BMY/NNP Short/NNP Term/NNP PowerRatings/NNP)
	(NOUN Co/NNP MRK/NNP)

----------------------------------
original sentence: 
Merck & Co MRK has Short Term PowerRatings at TradingMarkets.

POS tagged sentence: 
[('Merck', 'NNP'), ('&', 'CC'), ('Co', 'NNP'), ('MRK', 'NNP'), ('has', 'VBZ'), ('Short', 'NNP'), ('Term', 'NNP'), ('PowerRatings', 'NNP'), ('at', 'IN'), ('TradingMarkets', 'NNPS'), ('.', '.')]


ERTAGGED sentence: (S   (GPE Merck/NNP)   &/CC   Co/NNP   MRK/NNP   has/VBZ   (PERSON Short/NNP Term/NNP)   PowerRatings/NNP   at/IN   (ORGANIZATION TradingMarkets/NNPS)   ./.)Up/down number phrases to consider:
verb phrases to consider:
	(VERB   has/VBZ   Short/NNP   Term/NNP   PowerRatings/NNP   at/IN   TradingMarkets/NNPS)
noun phrases to consider:
	(NOUN Merck/NNP)
	(NOUN Co/NNP MRK/NNP)

----------------------------------
original sentence: 
Details on Merck & Co MRK Short Term PowerRatings is available at For full details on Eli Lilly & Company LLY .

POS tagged sentence: 
[('Details', 'NNS'), ('on', 'IN'), ('Merck', 'NNP'), ('&', 'CC'), ('Co', 'NNP'), ('MRK', 'NNP'), ('Short', 'NNP'), ('Term', 'NNP'), ('PowerRatings', 'NNP'), ('is', 'VBZ'), ('available', 'JJ'), ('at', 'IN'), ('For', 'NNP'), ('full', 'JJ'), ('details', 'NNS'), ('on', 'IN'), ('Eli', 'NNP'), ('Lilly', 'NNP'), ('&', 'CC'), ('Company', 'NNP'), ('LLY', 'NNP'), ('.', '.')]


ERTAGGED sentence: (S   Details/NNS   on/IN   (ORGANIZATION Merck/NNP)   &/CC   Co/NNP   MRK/NNP   Short/NNP   Term/NNP   PowerRatings/NNP   is/VBZ   available/JJ   at/IN   (ORGANIZATION For/NNP)   full/JJ   details/NNS   on/IN   (PERSON Eli/NNP Lilly/NNP)   &/CC   (ORGANIZATION Company/NNP)   LLY/NNP   ./.)Up/down number phrases to consider:
verb phrases to consider:
	(VERB   is/VBZ   available/JJ   at/IN   For/NNP   full/JJ   details/NNS   on/IN   Eli/NNP   Lilly/NNP)
noun phrases to consider:
	(NOUN Details/NNS)
	(NOUN Merck/NNP)
	(NOUN Co/NNP MRK/NNP Short/NNP Term/NNP)
	(NOUN PowerRatings/NNP)
	(NOUN Company/NNP LLY/NNP)

----------------------------------
original sentence: 
Eli Lilly & Company LLY has Short Term PowerRatings at TradingMarkets.

POS tagged sentence: 
[('Eli', 'NNP'), ('Lilly', 'NNP'), ('&', 'CC'), ('Company', 'NNP'), ('LLY', 'NNP'), ('has', 'VBZ'), ('Short', 'NNP'), ('Term', 'NNP'), ('PowerRatings', 'NNP'), ('at', 'IN'), ('TradingMarkets', 'NNPS'), ('.', '.')]


ERTAGGED sentence: (S   (PERSON Eli/NNP)   (ORGANIZATION Lilly/NNP)   &/CC   (ORGANIZATION Company/NNP)   LLY/NNP   has/VBZ   (PERSON Short/NNP Term/NNP)   PowerRatings/NNP   at/IN   (ORGANIZATION TradingMarkets/NNPS)   ./.)
----------------------------------
original sentence: 
Details on Eli Lilly & Company LLY Short Term PowerRatings is available at Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day.

POS tagged sentence: 
[('Details', 'NNS'), ('on', 'IN'), ('Eli', 'NNP'), ('Lilly', 'NNP'), ('&', 'CC'), ('Company', 'NNP'), ('LLY', 'NNP'), ('Short', 'NNP'), ('Term', 'NNP'), ('PowerRatings', 'NNP'), ('is', 'VBZ'), ('available', 'JJ'), ('at', 'IN'), ('Learn', 'NNP'), ('new', 'JJ'), ('strategies', 'NNS'), (',', ','), ('how', 'WRB'), ('to', 'TO'), ('trade', 'VB'), ('in', 'IN'), ('this', 'DT'), ('market', 'NN'), (',', ','), ('and', 'CC'), ('the', 'DT'), ('stocks', 'NNS'), ('you', 'PRP'), ('should', 'MD'), ('be', 'VB'), ('focusing', 'VBG'), ('on', 'IN'), ('each', 'DT'), ('day', 'NN'), ('.', '.')]


ERTAGGED sentence: (S   Details/NNS   on/IN   (PERSON Eli/NNP Lilly/NNP)   &/CC   (ORGANIZATION Company/NNP)   LLY/NNP   Short/NNP   Term/NNP   PowerRatings/NNP   is/VBZ   available/JJ   at/IN   (ORGANIZATION Learn/NNP)   new/JJ   strategies/NNS   ,/,   how/WRB   to/TO   trade/VB   in/IN   this/DT   market/NN   ,/,   and/CC   the/DT   stocks/NNS   you/PRP   should/MD   be/VB   focusing/VBG   on/IN   each/DT   day/NN   ./.)
----------------------------------
original sentence: 
Join us for our  20 minute tele seminars during the week.

POS tagged sentence: 
[('Join', 'NNP'), ('us', 'PRP'), ('for', 'IN'), ('our', 'PRP$'), ('20', 'CD'), ('minute', 'NN'), ('tele', 'NN'), ('seminars', 'NNS'), ('during', 'IN'), ('the', 'DT'), ('week', 'NN'), ('.', '.')]


ERTAGGED sentence: (S   Join/NNP   us/PRP   for/IN   our/PRP$   20/CD   minute/NN   tele/NN   seminars/NNS   during/IN   the/DT   week/NN   ./.)
----------------------------------
original sentence: 
Thursday April 29 12:30 PM Hear What Kevin Haggerty Sees in the Stock Market Today!

POS tagged sentence: 
[('Thursday', 'NNP'), ('April', 'NNP'), ('29', 'CD'), ('12', 'CD'), (':', ':'), ('30', 'CD'), ('PM', 'NNP'), ('Hear', 'NNP'), ('What', 'NNP'), ('Kevin', 'NNP'), ('Haggerty', 'NNP'), ('Sees', 'NNP'), ('in', 'IN'), ('the', 'DT'), ('Stock', 'NNP'), ('Market', 'NNP'), ('Today', 'NNP'), ('!', '.')]


ERTAGGED sentence: (S   Thursday/NNP   April/NNP   29/CD   12/CD   :/:   30/CD   PM/NNP   Hear/NNP   What/NNP   (PERSON Kevin/NNP Haggerty/NNP Sees/NNP)   in/IN   the/DT   Stock/NNP   (PERSON Market/NNP)   Today/NNP   !/.)
----------------------------------
original sentence: 
Wednesday April 28 01:00 PM Hear What Gary Kaltbaum Sees in the Stock Market Today!

POS tagged sentence: 
[('Wednesday', 'NNP'), ('April', 'NNP'), ('28', 'CD'), ('01', 'CD'), (':', ':'), ('00', 'CD'), ('PM', 'NNP'), ('Hear', 'NNP'), ('What', 'NNP'), ('Gary', 'NNP'), ('Kaltbaum', 'NNP'), ('Sees', 'NNP'), ('in', 'IN'), ('the', 'DT'), ('Stock', 'NNP'), ('Market', 'NNP'), ('Today', 'NNP'), ('!', '.')]


ERTAGGED sentence: (S   Wednesday/NNP   April/NNP   28/CD   01/CD   :/:   00/CD   PM/NNP   Hear/NNP   What/NNP   Gary/NNP   Kaltbaum/NNP   Sees/NNP   in/IN   the/DT   Stock/NNP   (PERSON Market/NNP)   Today/NNP   !/.)
----------------------------------
original sentence: 
* Attendance is strictly limited and are filled on a first come, first served basis. 

POS tagged sentence: 
[('*', '-NONE-'), ('Attendance', 'VB'), ('is', 'VBZ'), ('strictly', 'RB'), ('limited', 'VBN'), ('and', 'CC'), ('are', 'VBP'), ('filled', 'VBN'), ('on', 'IN'), ('a', 'DT'), ('first', 'JJ'), ('come', 'NN'), (',', ','), ('first', 'JJ'), ('served', 'VBD'), ('basis', 'NN'), ('.', '.')]


ERTAGGED sentence: (S   */-NONE-   Attendance/VB   is/VBZ   strictly/RB   limited/VBN   and/CC   are/VBP   filled/VBN   on/IN   a/DT   first/JJ   come/NN   ,/,   first/JJ   served/VBD   basis/NN   ./.)

veryneg:0	neg:0	pos:1	verypos:0	total:0